Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit

摘要

BackgroundAlthough neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol and phenobarbital for the treatment of cholestasis in a diverse NICU population.